Formulating and Implementing Pharmaceutical Pricing Policies: Challenges, Case Studies and Lessons Learned from Medicine Price Control
Editat de Zaheer-Ud-Din Babaren Limba Engleză Paperback – 4 aug 2025
- Covers the most updated pricing material on the drug pricing control policies
- Demonstrates in real terms, how a medicine pricing policy is formed in a country
- Discusses the empiric basis of forming a medicines pricing policy
Preț: 852.48 lei
Preț vechi: 1172.47 lei
-27% Nou
Puncte Express: 1279
Preț estimativ în valută:
150.87€ • 176.93$ • 132.28£
150.87€ • 176.93$ • 132.28£
Carte tipărită la comandă
Livrare economică 19 ianuarie-02 februarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443235184
ISBN-10: 044323518X
Pagini: 364
Dimensiuni: 152 x 229 x 20 mm
Greutate: 0.66 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 044323518X
Pagini: 364
Dimensiuni: 152 x 229 x 20 mm
Greutate: 0.66 kg
Editura: ELSEVIER SCIENCE
Cuprins
1. Pharmaceutical pricing policies: Introduction, key concepts and evidence synthesis
2. Analysis of anti-retroviral medicines prices: A review of literature
3. Evidence on pharmaceutical pricing policies in Europe
4. Pharmaceutical pricing policies in Italy
5. Pharmaceutical pricing policies in Indonesia
6. Canada’s medicine pricing policies: implementation strategies and models
7. Pharmaceutical pricing policies in Thailand
8. Pharmaceutical Pricing Policies in China: An Evidence Synthesis Analysis
9. Strategies for medicine pricing in Southeast Asia
10. Pharmaceutical pricing policies in Syria
11. Pharmaceutical pricing policies in Finland- An example of uptake of less expensive biologic medicines
12. Integrating Citizens’ Voices in Pharmaceutical Pricing and Reimbursement
13. Pharmaceutical pricing policies in Spain
14. Pharmaceutical pricing strategies in the US
15. Money matters – How financing for medicines R&D affects medicines, and what to do about it
16. The role of Civil Society Organizations ensuring price transparency
17. How to Price Advanced Therapies? Mixed approach for valuing a new CAR-T Cell for Multiple Myeloma in Brazil
18. Pharmaceutical pricing policies in Greece
2. Analysis of anti-retroviral medicines prices: A review of literature
3. Evidence on pharmaceutical pricing policies in Europe
4. Pharmaceutical pricing policies in Italy
5. Pharmaceutical pricing policies in Indonesia
6. Canada’s medicine pricing policies: implementation strategies and models
7. Pharmaceutical pricing policies in Thailand
8. Pharmaceutical Pricing Policies in China: An Evidence Synthesis Analysis
9. Strategies for medicine pricing in Southeast Asia
10. Pharmaceutical pricing policies in Syria
11. Pharmaceutical pricing policies in Finland- An example of uptake of less expensive biologic medicines
12. Integrating Citizens’ Voices in Pharmaceutical Pricing and Reimbursement
13. Pharmaceutical pricing policies in Spain
14. Pharmaceutical pricing strategies in the US
15. Money matters – How financing for medicines R&D affects medicines, and what to do about it
16. The role of Civil Society Organizations ensuring price transparency
17. How to Price Advanced Therapies? Mixed approach for valuing a new CAR-T Cell for Multiple Myeloma in Brazil
18. Pharmaceutical pricing policies in Greece